Thyroid hormone levels in children with Prader–Willi syndrome before and during growth hormone treatment
- 20 July 2007
- journal article
- research article
- Published by Wiley in Clinical Endocrinology
- Vol. 67 (3), 449-456
- https://doi.org/10.1111/j.1365-2265.2007.02910.x
Abstract
Background Prader–Willi syndrome (PWS) is a neurogenetic disorder characterized by muscular hypotonia, psychomotor delay, obesity and short stature. Several endocrine abnormalities have been described, including GH deficiency and hypogonadotrophic hypogonadism. Published data on thyroid hormone levels in PWS children are very limited. Objective To evaluate thyroid function in children with PWS, before and during GH treatment. Design/patients At baseline, serum levels of T4, free T4 (fT4), T3, reverse T3 (rT3) and TSH were assessed in 75 PWS children. After 1 year, assessments were repeated in 57 of the them. These children participated in a randomized study with two groups: group A (n = 34) treated with 1 mg GH/m2/day and group B (n = 23) as controls. Results Median age (interquartile range, IQR) of the total group at baseline was 4·7 (2·7–7·6) years. Median (IQR) TSH level was –0·1 SDS (–0·5 to 0·5), T4 level –0·6 SDS (–1·7 to 0·0) and fT4 level –0·8 SDS (–1·3 to –0·3), the latter two being significantly lower than 0 SDS. T3 level, at 0·3 SDS (–0·3 to 0·9), was significantly higher than 0 SDS. After 1 year of GH treatment, fT4 decreased significantly from –0·8 SDS (–1·5 to –0·2) to –1·4 SDS (–1·6 to –0·7), compared to no change in untreated PWS children. However, T3 did not change, at 0·3 SDS (–0·1 to 0·8). Conclusions We found normal fT4 levels in most PWS children. During GH treatment, fT4 decreased significantly to low‐normal levels. TSH levels remained normal. T3 levels were relatively high or normal, both before and during GH treatment, indicating that PWS children have increased T4 to T3 conversion.Keywords
This publication has 41 references indexed in Scilit:
- Circulating adiponectin levels, body composition and obesity-related variables in Prader–Willi syndrome: comparison with obese subjectsInternational Journal of Obesity, 2005
- Type 2 iodothyronine deiodinase is the major source of plasma T3 in euthyroid humansJCI Insight, 2005
- Thyroid hormones before and after weight loss in obesityArchives of Disease in Childhood, 2002
- Congenital Hypothyroidism with Prader-Willi Syndrome: Patient ReportJournal of Pediatric Endocrinology and Metabolism, 2002
- Impact of Growth Hormone Administration on Other Hormonal AxesHormone Research in Paediatrics, 1999
- Inherited microdeletions in the Angelman and Prader–Willi syndromes define an imprinting centre on human chromosome 15Nature Genetics, 1995
- Genomic imprinting and uniparental disomy in Angelman and Prader‐Willi syndromes: A reviewAmerican Journal of Medical Genetics, 1993
- Nocturnal thyrotropin surge in growth hormone-deficient childrenThe Journal of Pediatrics, 1992
- Growth and thyroid function in children treated with growth hormoneThe Journal of Pediatrics, 1992
- RELATION OF THYROID HORMONES TO BODY-WEIGHTThe Lancet, 1976